The TMA assay has shown that 94 of the 214 GCA tumors (44%) were strongly stained with anti-CYR61, and 120 tumor samples (56%) had weak or no staining (Figure 1B), indicating that CYR61 is overexpressed in GCA with a high frequency. The gene discussed is CCN1; the disease is neoplasm.